nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Tamoxifen—pancreatic cancer	0.0311	0.24	CbGbCtD
Tadalafil—CYP3A4—Erlotinib—pancreatic cancer	0.0264	0.204	CbGbCtD
Tadalafil—CYP3A4—Irinotecan—pancreatic cancer	0.0239	0.185	CbGbCtD
Tadalafil—CYP3A4—Docetaxel—pancreatic cancer	0.0175	0.135	CbGbCtD
Tadalafil—CYP3A4—Sunitinib—pancreatic cancer	0.0174	0.135	CbGbCtD
Tadalafil—CYP3A4—Doxorubicin—pancreatic cancer	0.013	0.101	CbGbCtD
Tadalafil—PDE11A—Platelet homeostasis—PPP2R5B—pancreatic cancer	0.00508	0.0635	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—PPP2R5B—pancreatic cancer	0.00453	0.0566	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—SCT—pancreatic cancer	0.00312	0.039	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—GLP1R—pancreatic cancer	0.0029	0.0363	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—IAPP—pancreatic cancer	0.00257	0.0321	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—PTHLH—pancreatic cancer	0.00247	0.0309	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—GCG—pancreatic cancer	0.00201	0.0252	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IFNA5—pancreatic cancer	0.00121	0.0151	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PPP2R5B—pancreatic cancer	0.00114	0.0142	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IFNA5—pancreatic cancer	0.00107	0.0134	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PPP2R5B—pancreatic cancer	0.00101	0.0127	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRLHR—pancreatic cancer	0.000942	0.0118	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000882	0.011	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GDI2—pancreatic cancer	0.000864	0.0108	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GDI1—pancreatic cancer	0.000864	0.0108	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000846	0.0106	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PPY—pancreatic cancer	0.000829	0.0104	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000814	0.0102	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—SSTR3—pancreatic cancer	0.000801	0.01	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000786	0.00982	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—SSTR1—pancreatic cancer	0.000768	0.0096	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000766	0.000969	CcSEcCtD
Tadalafil—Fatigue—Gemcitabine—pancreatic cancer	0.000765	0.000968	CcSEcCtD
Tadalafil—Gastritis—Epirubicin—pancreatic cancer	0.000765	0.000967	CcSEcCtD
Tadalafil—Pain—Gemcitabine—pancreatic cancer	0.000759	0.00096	CcSEcCtD
Tadalafil—Constipation—Gemcitabine—pancreatic cancer	0.000759	0.00096	CcSEcCtD
Tadalafil—Nausea—Erlotinib—pancreatic cancer	0.000759	0.00096	CcSEcCtD
Tadalafil—Diarrhoea—Sunitinib—pancreatic cancer	0.000757	0.000957	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PPY—pancreatic cancer	0.000753	0.00941	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000753	0.000953	CcSEcCtD
Tadalafil—Influenza—Epirubicin—pancreatic cancer	0.000747	0.000945	CcSEcCtD
Tadalafil—Dysphagia—Epirubicin—pancreatic cancer	0.000747	0.000945	CcSEcCtD
Tadalafil—Back pain—Docetaxel—pancreatic cancer	0.000746	0.000944	CcSEcCtD
Tadalafil—Pain—Fluorouracil—pancreatic cancer	0.000746	0.000944	CcSEcCtD
Tadalafil—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000745	0.000942	CcSEcCtD
Tadalafil—Muscle spasms—Docetaxel—pancreatic cancer	0.000742	0.000938	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—SSTR2—pancreatic cancer	0.000739	0.00924	CbGpPWpGaD
Tadalafil—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000738	0.000934	CcSEcCtD
Tadalafil—Dizziness—Sunitinib—pancreatic cancer	0.000731	0.000925	CcSEcCtD
Tadalafil—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00073	0.000924	CcSEcCtD
Tadalafil—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00073	0.000924	CcSEcCtD
Tadalafil—Angina pectoris—Epirubicin—pancreatic cancer	0.000728	0.00092	CcSEcCtD
Tadalafil—Breast disorder—Doxorubicin—pancreatic cancer	0.000723	0.000914	CcSEcCtD
Tadalafil—Abdominal pain—Irinotecan—pancreatic cancer	0.00072	0.000911	CcSEcCtD
Tadalafil—Bronchitis—Epirubicin—pancreatic cancer	0.000718	0.000909	CcSEcCtD
Tadalafil—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000715	0.000904	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCKBR—pancreatic cancer	0.000714	0.00892	CbGpPWpGaD
Tadalafil—Gastritis—Doxorubicin—pancreatic cancer	0.000708	0.000895	CcSEcCtD
Tadalafil—Vomiting—Sunitinib—pancreatic cancer	0.000703	0.000889	CcSEcCtD
Tadalafil—Rash—Sunitinib—pancreatic cancer	0.000697	0.000882	CcSEcCtD
Tadalafil—Dermatitis—Sunitinib—pancreatic cancer	0.000697	0.000881	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000694	0.000878	CcSEcCtD
Tadalafil—Urticaria—Fluorouracil—pancreatic cancer	0.000693	0.000877	CcSEcCtD
Tadalafil—Headache—Sunitinib—pancreatic cancer	0.000693	0.000876	CcSEcCtD
Tadalafil—Syncope—Docetaxel—pancreatic cancer	0.000692	0.000875	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—pancreatic cancer	0.000691	0.000874	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—pancreatic cancer	0.000691	0.000874	CcSEcCtD
Tadalafil—Palpitations—Docetaxel—pancreatic cancer	0.000682	0.000862	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—CD44—pancreatic cancer	0.000682	0.00852	CbGpPWpGaD
Tadalafil—Loss of consciousness—Docetaxel—pancreatic cancer	0.000678	0.000858	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—GAST—pancreatic cancer	0.000676	0.00845	CbGpPWpGaD
Tadalafil—Cough—Docetaxel—pancreatic cancer	0.000673	0.000852	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—pancreatic cancer	0.000673	0.000851	CcSEcCtD
Tadalafil—Hypersensitivity—Irinotecan—pancreatic cancer	0.000671	0.000849	CcSEcCtD
Tadalafil—Convulsion—Docetaxel—pancreatic cancer	0.000669	0.000846	CcSEcCtD
Tadalafil—Hypertension—Docetaxel—pancreatic cancer	0.000666	0.000843	CcSEcCtD
Tadalafil—Infestation—Epirubicin—pancreatic cancer	0.000666	0.000842	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—pancreatic cancer	0.000666	0.000842	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—pancreatic cancer	0.000665	0.000841	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—IFNA1—pancreatic cancer	0.00066	0.00825	CbGpPWpGaD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00066	0.000835	CcSEcCtD
Tadalafil—Arthralgia—Docetaxel—pancreatic cancer	0.000657	0.000831	CcSEcCtD
Tadalafil—Chest pain—Docetaxel—pancreatic cancer	0.000657	0.000831	CcSEcCtD
Tadalafil—Myalgia—Docetaxel—pancreatic cancer	0.000657	0.000831	CcSEcCtD
Tadalafil—Nausea—Sunitinib—pancreatic cancer	0.000657	0.000831	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—pancreatic cancer	0.000655	0.000828	CcSEcCtD
Tadalafil—Asthenia—Irinotecan—pancreatic cancer	0.000654	0.000827	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000652	0.000825	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—pancreatic cancer	0.000647	0.000819	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—pancreatic cancer	0.000647	0.000819	CcSEcCtD
Tadalafil—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000643	0.000813	CcSEcCtD
Tadalafil—Dry mouth—Docetaxel—pancreatic cancer	0.000642	0.000813	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000642	0.000812	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—SCT—pancreatic cancer	0.000641	0.00801	CbGpPWpGaD
Tadalafil—Sweating—Epirubicin—pancreatic cancer	0.000638	0.000808	CcSEcCtD
Tadalafil—Asthenia—Gemcitabine—pancreatic cancer	0.000637	0.000805	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—pancreatic cancer	0.000635	0.000803	CcSEcCtD
Tadalafil—Oedema—Docetaxel—pancreatic cancer	0.00063	0.000796	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—pancreatic cancer	0.000628	0.000794	CcSEcCtD
Tadalafil—Pruritus—Gemcitabine—pancreatic cancer	0.000628	0.000794	CcSEcCtD
Tadalafil—Infection—Docetaxel—pancreatic cancer	0.000626	0.000791	CcSEcCtD
Tadalafil—Diarrhoea—Irinotecan—pancreatic cancer	0.000623	0.000788	CcSEcCtD
Tadalafil—Shock—Docetaxel—pancreatic cancer	0.00062	0.000784	CcSEcCtD
Tadalafil—Nervous system disorder—Docetaxel—pancreatic cancer	0.000618	0.000781	CcSEcCtD
Tadalafil—Pruritus—Fluorouracil—pancreatic cancer	0.000617	0.000781	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—pancreatic cancer	0.000616	0.000779	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—pancreatic cancer	0.000616	0.000779	CcSEcCtD
Tadalafil—Tachycardia—Docetaxel—pancreatic cancer	0.000615	0.000777	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—IFNA2—pancreatic cancer	0.000615	0.00768	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GAST—pancreatic cancer	0.000614	0.00767	CbGpPWpGaD
Tadalafil—Skin disorder—Docetaxel—pancreatic cancer	0.000612	0.000774	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CCK—pancreatic cancer	0.000611	0.00764	CbGpPWpGaD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000611	0.000773	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—CD44—pancreatic cancer	0.000608	0.00759	CbGpPWpGaD
Tadalafil—Diarrhoea—Gemcitabine—pancreatic cancer	0.000607	0.000768	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—pancreatic cancer	0.000606	0.000766	CcSEcCtD
Tadalafil—Dizziness—Irinotecan—pancreatic cancer	0.000602	0.000762	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—pancreatic cancer	0.000601	0.00076	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—pancreatic cancer	0.000599	0.000758	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000599	0.000758	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000599	0.000758	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—pancreatic cancer	0.000598	0.000756	CcSEcCtD
Tadalafil—Diarrhoea—Fluorouracil—pancreatic cancer	0.000597	0.000755	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CNR2—pancreatic cancer	0.000596	0.00745	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000596	0.00745	CbGpPWpGaD
Tadalafil—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000595	0.000752	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—pancreatic cancer	0.000593	0.00075	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—pancreatic cancer	0.000591	0.000747	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00059	0.000747	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—pancreatic cancer	0.000589	0.000745	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—IFNA1—pancreatic cancer	0.000588	0.00735	CbGpPWpGaD
Tadalafil—Hypotension—Docetaxel—pancreatic cancer	0.000588	0.000744	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—pancreatic cancer	0.000588	0.000743	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000587	0.000743	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000586	0.00733	CbGpPWpGaD
Tadalafil—Urethral disorder—Epirubicin—pancreatic cancer	0.000586	0.000741	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—SCT—pancreatic cancer	0.000582	0.00727	CbGpPWpGaD
Tadalafil—Epistaxis—Doxorubicin—pancreatic cancer	0.000581	0.000735	CcSEcCtD
Tadalafil—Vomiting—Irinotecan—pancreatic cancer	0.000579	0.000733	CcSEcCtD
Tadalafil—Dizziness—Fluorouracil—pancreatic cancer	0.000577	0.00073	CcSEcCtD
Tadalafil—Rash—Irinotecan—pancreatic cancer	0.000574	0.000726	CcSEcCtD
Tadalafil—Dermatitis—Irinotecan—pancreatic cancer	0.000574	0.000726	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000574	0.000726	CcSEcCtD
Tadalafil—Headache—Irinotecan—pancreatic cancer	0.000571	0.000722	CcSEcCtD
Tadalafil—Insomnia—Docetaxel—pancreatic cancer	0.00057	0.00072	CcSEcCtD
Tadalafil—Paraesthesia—Docetaxel—pancreatic cancer	0.000565	0.000715	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—pancreatic cancer	0.000565	0.000715	CcSEcCtD
Tadalafil—Vomiting—Gemcitabine—pancreatic cancer	0.000564	0.000714	CcSEcCtD
Tadalafil—Dyspnoea—Docetaxel—pancreatic cancer	0.000561	0.00071	CcSEcCtD
Tadalafil—Somnolence—Docetaxel—pancreatic cancer	0.00056	0.000708	CcSEcCtD
Tadalafil—Rash—Gemcitabine—pancreatic cancer	0.000559	0.000708	CcSEcCtD
Tadalafil—Dermatitis—Gemcitabine—pancreatic cancer	0.000559	0.000707	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—pancreatic cancer	0.000559	0.000707	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—pancreatic cancer	0.000557	0.000705	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PRLHR—pancreatic cancer	0.000557	0.00695	CbGpPWpGaD
Tadalafil—Haemoglobin—Doxorubicin—pancreatic cancer	0.000556	0.000703	CcSEcCtD
Tadalafil—Headache—Gemcitabine—pancreatic cancer	0.000556	0.000703	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCK—pancreatic cancer	0.000555	0.00694	CbGpPWpGaD
Tadalafil—Cardiac disorder—Epirubicin—pancreatic cancer	0.000555	0.000702	CcSEcCtD
Tadalafil—Flushing—Epirubicin—pancreatic cancer	0.000555	0.000702	CcSEcCtD
Tadalafil—Vomiting—Fluorouracil—pancreatic cancer	0.000555	0.000702	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—pancreatic cancer	0.000555	0.000701	CcSEcCtD
Tadalafil—Dyspepsia—Docetaxel—pancreatic cancer	0.000554	0.000701	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—pancreatic cancer	0.000553	0.0007	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00055	0.000696	CcSEcCtD
Tadalafil—Rash—Fluorouracil—pancreatic cancer	0.00055	0.000696	CcSEcCtD
Tadalafil—Dermatitis—Fluorouracil—pancreatic cancer	0.00055	0.000695	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—pancreatic cancer	0.000549	0.000694	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—IFNA2—pancreatic cancer	0.000548	0.00684	CbGpPWpGaD
Tadalafil—Headache—Fluorouracil—pancreatic cancer	0.000547	0.000691	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000546	0.000691	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000545	0.000689	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000544	0.000688	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000544	0.000688	CcSEcCtD
Tadalafil—Fatigue—Docetaxel—pancreatic cancer	0.000543	0.000687	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—pancreatic cancer	0.000542	0.000686	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—pancreatic cancer	0.000542	0.000686	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CNR2—pancreatic cancer	0.000541	0.00676	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GLP1R—pancreatic cancer	0.000541	0.00676	CbGpPWpGaD
Tadalafil—Nausea—Irinotecan—pancreatic cancer	0.000541	0.000684	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—pancreatic cancer	0.00054	0.000683	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000539	0.000681	CcSEcCtD
Tadalafil—Pain—Docetaxel—pancreatic cancer	0.000538	0.000681	CcSEcCtD
Tadalafil—Constipation—Docetaxel—pancreatic cancer	0.000538	0.000681	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCKAR—pancreatic cancer	0.000532	0.00665	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IAPP—pancreatic cancer	0.000528	0.0066	CbGpPWpGaD
Tadalafil—Nausea—Gemcitabine—pancreatic cancer	0.000527	0.000667	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—pancreatic cancer	0.000524	0.000662	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ACVR1B—pancreatic cancer	0.000523	0.00654	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ZNRF3—pancreatic cancer	0.000523	0.00654	CbGpPWpGaD
Tadalafil—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000523	0.000662	CcSEcCtD
Tadalafil—Nausea—Fluorouracil—pancreatic cancer	0.000518	0.000655	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—pancreatic cancer	0.000517	0.000654	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—pancreatic cancer	0.000516	0.000652	CcSEcCtD
Tadalafil—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000515	0.000651	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—pancreatic cancer	0.000513	0.000649	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000513	0.000649	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000507	0.00633	CbGpPWpGaD
Tadalafil—Back pain—Epirubicin—pancreatic cancer	0.000503	0.000637	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—pancreatic cancer	0.000502	0.000635	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—pancreatic cancer	0.0005	0.000633	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—pancreatic cancer	0.0005	0.000632	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000499	0.000631	CcSEcCtD
Tadalafil—Abdominal pain—Docetaxel—pancreatic cancer	0.000498	0.00063	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—pancreatic cancer	0.00049	0.00062	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—SHH—pancreatic cancer	0.000485	0.00606	CbGpPWpGaD
Tadalafil—Mental disorder—Doxorubicin—pancreatic cancer	0.000485	0.000613	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—IAPP—pancreatic cancer	0.000479	0.00599	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SSTR3—pancreatic cancer	0.000473	0.00591	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DTX1—pancreatic cancer	0.000473	0.00591	CbGpPWpGaD
Tadalafil—Vertigo—Epirubicin—pancreatic cancer	0.000468	0.000591	CcSEcCtD
Tadalafil—Syncope—Epirubicin—pancreatic cancer	0.000467	0.00059	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—pancreatic cancer	0.000466	0.000589	CcSEcCtD
Tadalafil—Hypersensitivity—Docetaxel—pancreatic cancer	0.000464	0.000587	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—SST—pancreatic cancer	0.000463	0.00579	CbGpPWpGaD
Tadalafil—Muscle spasms—Doxorubicin—pancreatic cancer	0.000463	0.000586	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PTHLH—pancreatic cancer	0.00046	0.00575	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PTCH1—pancreatic cancer	0.00046	0.00575	CbGpPWpGaD
Tadalafil—Palpitations—Epirubicin—pancreatic cancer	0.00046	0.000582	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—pancreatic cancer	0.000457	0.000579	CcSEcCtD
Tadalafil—Cough—Epirubicin—pancreatic cancer	0.000454	0.000574	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—pancreatic cancer	0.000454	0.000574	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SSTR1—pancreatic cancer	0.000454	0.00567	CbGpPWpGaD
Tadalafil—Asthenia—Docetaxel—pancreatic cancer	0.000452	0.000571	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—pancreatic cancer	0.000451	0.00057	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—pancreatic cancer	0.000449	0.000568	CcSEcCtD
Tadalafil—Pruritus—Docetaxel—pancreatic cancer	0.000446	0.000564	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PPY—pancreatic cancer	0.000445	0.00556	CbGpPWpGaD
Tadalafil—Arthralgia—Epirubicin—pancreatic cancer	0.000443	0.00056	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—pancreatic cancer	0.000443	0.00056	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—pancreatic cancer	0.000443	0.00056	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00044	0.000557	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—pancreatic cancer	0.000438	0.000554	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SSTR2—pancreatic cancer	0.000437	0.00546	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLAU—pancreatic cancer	0.000436	0.00545	CbGpPWpGaD
Tadalafil—Dry mouth—Epirubicin—pancreatic cancer	0.000433	0.000548	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—pancreatic cancer	0.000433	0.000547	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—pancreatic cancer	0.000432	0.000546	CcSEcCtD
Tadalafil—Diarrhoea—Docetaxel—pancreatic cancer	0.000431	0.000545	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CNR1—pancreatic cancer	0.000428	0.00534	CbGpPWpGaD
Tadalafil—Palpitations—Doxorubicin—pancreatic cancer	0.000426	0.000538	CcSEcCtD
Tadalafil—Oedema—Epirubicin—pancreatic cancer	0.000425	0.000537	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000423	0.000535	CcSEcCtD
Tadalafil—Infection—Epirubicin—pancreatic cancer	0.000422	0.000534	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CCKBR—pancreatic cancer	0.000422	0.00527	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—SST—pancreatic cancer	0.000421	0.00526	CbGpPWpGaD
Tadalafil—Cough—Doxorubicin—pancreatic cancer	0.00042	0.000531	CcSEcCtD
Tadalafil—Shock—Epirubicin—pancreatic cancer	0.000418	0.000529	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—pancreatic cancer	0.000417	0.000528	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—pancreatic cancer	0.000417	0.000527	CcSEcCtD
Tadalafil—Dizziness—Docetaxel—pancreatic cancer	0.000416	0.000527	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—pancreatic cancer	0.000416	0.000526	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—pancreatic cancer	0.000415	0.000524	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—GCG—pancreatic cancer	0.000413	0.00516	CbGpPWpGaD
Tadalafil—Skin disorder—Epirubicin—pancreatic cancer	0.000413	0.000522	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000411	0.000519	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—pancreatic cancer	0.00041	0.000519	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—pancreatic cancer	0.00041	0.000519	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—pancreatic cancer	0.00041	0.000519	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000407	0.000515	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—pancreatic cancer	0.000405	0.000512	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—pancreatic cancer	0.000401	0.000507	CcSEcCtD
Tadalafil—Vomiting—Docetaxel—pancreatic cancer	0.0004	0.000506	CcSEcCtD
Tadalafil—Rash—Docetaxel—pancreatic cancer	0.000397	0.000502	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—pancreatic cancer	0.000397	0.000502	CcSEcCtD
Tadalafil—Dermatitis—Docetaxel—pancreatic cancer	0.000397	0.000502	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—DTX4—pancreatic cancer	0.000397	0.00496	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GLI1—pancreatic cancer	0.000397	0.00496	CbGpPWpGaD
Tadalafil—Headache—Docetaxel—pancreatic cancer	0.000394	0.000499	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000394	0.00492	CbGpPWpGaD
Tadalafil—Oedema—Doxorubicin—pancreatic cancer	0.000393	0.000497	CcSEcCtD
Tadalafil—Infection—Doxorubicin—pancreatic cancer	0.00039	0.000494	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PLAU—pancreatic cancer	0.000389	0.00486	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CNR1—pancreatic cancer	0.000388	0.00485	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CG—pancreatic cancer	0.000388	0.00485	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000387	0.000489	CcSEcCtD
Tadalafil—Shock—Doxorubicin—pancreatic cancer	0.000387	0.000489	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—NRP1—pancreatic cancer	0.000386	0.00482	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000386	0.00482	CbGpPWpGaD
Tadalafil—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000385	0.000487	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—pancreatic cancer	0.000384	0.000486	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—pancreatic cancer	0.000384	0.000485	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—EGF—pancreatic cancer	0.000384	0.00479	CbGpPWpGaD
Tadalafil—Skin disorder—Doxorubicin—pancreatic cancer	0.000382	0.000483	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—pancreatic cancer	0.000381	0.000482	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00038	0.000481	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—pancreatic cancer	0.000379	0.000479	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—pancreatic cancer	0.000378	0.000478	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—GCG—pancreatic cancer	0.000375	0.00469	CbGpPWpGaD
Tadalafil—Nausea—Docetaxel—pancreatic cancer	0.000374	0.000473	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—pancreatic cancer	0.000374	0.000473	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HEY2—pancreatic cancer	0.000371	0.00464	CbGpPWpGaD
Tadalafil—Hypotension—Doxorubicin—pancreatic cancer	0.000367	0.000464	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000367	0.000464	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—pancreatic cancer	0.000366	0.000463	CcSEcCtD
Tadalafil—Pain—Epirubicin—pancreatic cancer	0.000363	0.000459	CcSEcCtD
Tadalafil—Constipation—Epirubicin—pancreatic cancer	0.000363	0.000459	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—GAST—pancreatic cancer	0.000363	0.00453	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000358	0.000453	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—AGTR1—pancreatic cancer	0.000358	0.00447	CbGpPWpGaD
Tadalafil—Insomnia—Doxorubicin—pancreatic cancer	0.000355	0.00045	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—pancreatic cancer	0.000353	0.000446	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—pancreatic cancer	0.00035	0.000443	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—pancreatic cancer	0.000349	0.000442	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000347	0.000439	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—pancreatic cancer	0.000346	0.000438	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PIK3CG—pancreatic cancer	0.000346	0.00432	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SCT—pancreatic cancer	0.000344	0.0043	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HEY1—pancreatic cancer	0.000344	0.0043	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—EGF—pancreatic cancer	0.000342	0.00427	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CD—pancreatic cancer	0.000341	0.00426	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000339	0.000429	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—pancreatic cancer	0.000339	0.000429	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—pancreatic cancer	0.000337	0.000427	CcSEcCtD
Tadalafil—Pain—Doxorubicin—pancreatic cancer	0.000336	0.000425	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—pancreatic cancer	0.000336	0.000425	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—pancreatic cancer	0.000336	0.000425	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CCK—pancreatic cancer	0.000328	0.0041	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000321	0.000406	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CNR2—pancreatic cancer	0.00032	0.00399	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GLP1R—pancreatic cancer	0.00032	0.00399	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCKAR—pancreatic cancer	0.000314	0.00393	CbGpPWpGaD
Tadalafil—Hypersensitivity—Epirubicin—pancreatic cancer	0.000313	0.000396	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—pancreatic cancer	0.000312	0.000395	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—pancreatic cancer	0.000311	0.000393	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—JAG2—pancreatic cancer	0.000305	0.00381	CbGpPWpGaD
Tadalafil—Asthenia—Epirubicin—pancreatic cancer	0.000305	0.000385	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PIK3CD—pancreatic cancer	0.000304	0.0038	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MEN1—pancreatic cancer	0.000301	0.00376	CbGpPWpGaD
Tadalafil—Pruritus—Epirubicin—pancreatic cancer	0.0003	0.00038	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PIK3CB—pancreatic cancer	0.000297	0.00371	CbGpPWpGaD
Tadalafil—Diarrhoea—Epirubicin—pancreatic cancer	0.000291	0.000368	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00029	0.000366	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SHH—pancreatic cancer	0.000287	0.00358	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000285	0.00356	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IAPP—pancreatic cancer	0.000283	0.00354	CbGpPWpGaD
Tadalafil—Asthenia—Doxorubicin—pancreatic cancer	0.000282	0.000357	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—pancreatic cancer	0.000281	0.000355	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—pancreatic cancer	0.000278	0.000352	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PTHLH—pancreatic cancer	0.000272	0.0034	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTCH1—pancreatic cancer	0.000272	0.0034	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000272	0.00339	CbGpPWpGaD
Tadalafil—Vomiting—Epirubicin—pancreatic cancer	0.00027	0.000342	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—pancreatic cancer	0.000269	0.00034	CcSEcCtD
Tadalafil—Rash—Epirubicin—pancreatic cancer	0.000268	0.000339	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—pancreatic cancer	0.000268	0.000338	CcSEcCtD
Tadalafil—Headache—Epirubicin—pancreatic cancer	0.000266	0.000337	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PIK3CB—pancreatic cancer	0.000265	0.00331	CbGpPWpGaD
Tadalafil—Dizziness—Doxorubicin—pancreatic cancer	0.00026	0.000329	CcSEcCtD
Tadalafil—Nausea—Epirubicin—pancreatic cancer	0.000252	0.000319	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—pancreatic cancer	0.00025	0.000316	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SST—pancreatic cancer	0.000249	0.00311	CbGpPWpGaD
Tadalafil—Rash—Doxorubicin—pancreatic cancer	0.000248	0.000313	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—pancreatic cancer	0.000248	0.000313	CcSEcCtD
Tadalafil—Headache—Doxorubicin—pancreatic cancer	0.000246	0.000311	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000245	0.00306	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JAG1—pancreatic cancer	0.000243	0.00304	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000242	0.00303	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SRC—pancreatic cancer	0.000238	0.00298	CbGpPWpGaD
Tadalafil—Nausea—Doxorubicin—pancreatic cancer	0.000233	0.000295	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—VEGFA—pancreatic cancer	0.000232	0.0029	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CNR1—pancreatic cancer	0.000229	0.00287	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NRAS—pancreatic cancer	0.000229	0.00286	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000223	0.00278	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GCG—pancreatic cancer	0.000222	0.00277	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000216	0.00269	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB1—pancreatic cancer	0.000213	0.00266	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SRC—pancreatic cancer	0.000212	0.00265	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR1—pancreatic cancer	0.000211	0.00264	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STK11—pancreatic cancer	0.000208	0.0026	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—pancreatic cancer	0.000207	0.00258	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NRAS—pancreatic cancer	0.000204	0.00255	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—KRAS—pancreatic cancer	0.000197	0.00246	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000196	0.00245	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TGFB1—pancreatic cancer	0.00019	0.00237	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000188	0.00235	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SMAD4—pancreatic cancer	0.000182	0.00228	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CA—pancreatic cancer	0.000181	0.00226	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000181	0.00226	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HES1—pancreatic cancer	0.000178	0.00223	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—KRAS—pancreatic cancer	0.000176	0.0022	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—pancreatic cancer	0.000175	0.00219	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000171	0.00213	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—HRAS—pancreatic cancer	0.000168	0.0021	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000164	0.00205	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CA—pancreatic cancer	0.000162	0.00202	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—pancreatic cancer	0.000156	0.00195	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TERT—pancreatic cancer	0.000156	0.00195	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—HRAS—pancreatic cancer	0.000149	0.00187	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HIF1A—pancreatic cancer	0.000149	0.00187	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TSC2—pancreatic cancer	0.000149	0.00186	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—pancreatic cancer	0.000148	0.00185	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—pancreatic cancer	0.000146	0.00182	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KDR—pancreatic cancer	0.000143	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000136	0.0017	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000135	0.00168	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—pancreatic cancer	0.000132	0.00165	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000132	0.00164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NRAS—pancreatic cancer	0.000132	0.00164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGF—pancreatic cancer	0.00013	0.00162	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—pancreatic cancer	0.00012	0.0015	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000116	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000115	0.00143	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KRAS—pancreatic cancer	0.000113	0.00141	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000104	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000101	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—pancreatic cancer	9.69e-05	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HRAS—pancreatic cancer	9.62e-05	0.0012	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—pancreatic cancer	9.36e-05	0.00117	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—pancreatic cancer	9.27e-05	0.00116	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCND1—pancreatic cancer	9.02e-05	0.00113	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CTNNB1—pancreatic cancer	8.94e-05	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—pancreatic cancer	8.76e-05	0.00109	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTEN—pancreatic cancer	8.71e-05	0.00109	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—pancreatic cancer	8.5e-05	0.00106	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SRC—pancreatic cancer	8.08e-05	0.00101	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—pancreatic cancer	7.87e-05	0.000983	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—pancreatic cancer	7.79e-05	0.000973	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NRAS—pancreatic cancer	7.77e-05	0.000971	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MYC—pancreatic cancer	7.24e-05	0.000904	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—pancreatic cancer	7.22e-05	0.000902	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—pancreatic cancer	7.08e-05	0.000885	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KRAS—pancreatic cancer	6.69e-05	0.000836	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CA—pancreatic cancer	6.14e-05	0.000768	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—pancreatic cancer	5.94e-05	0.000743	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HRAS—pancreatic cancer	5.68e-05	0.00071	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.23e-05	0.000654	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—pancreatic cancer	5.02e-05	0.000627	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.54e-05	0.000567	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.97e-05	0.000496	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.2e-05	0.000399	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.15e-05	0.000393	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.98e-05	0.000373	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CD44—pancreatic cancer	2.31e-05	0.000289	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCG—pancreatic cancer	2.22e-05	0.000277	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—STK11—pancreatic cancer	2.08e-05	0.00026	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.79e-05	0.000224	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—pancreatic cancer	1.46e-05	0.000182	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.32e-05	0.000164	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.27e-05	0.000159	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.16e-05	0.000144	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—pancreatic cancer	9.99e-06	0.000125	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTEN—pancreatic cancer	8.71e-06	0.000109	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.14e-06	7.68e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.02e-06	6.27e-05	CbGpPWpGaD
